cytarabine has been researched along with Exanthem in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Foutouhi, S; Kiuru, M; Simmons, E; Tartar, DM | 1 |
| Ang, AL; Ho, LP; Ng, HJ; Ong, SY; Yeo, PM | 1 |
| Boutault, R; Debord, C; Eveillard, M; Grain, A; Rialland, F; Theisen, O | 1 |
| Bhatnagar, N; Jones, H; Wan Ariffin, E | 1 |
| Ammannagari, N; Kaewpoowat, Q; Patel, A; Ratanapo, S | 1 |
| Fox, LP; Liu, F; Ruben, BS; Truong, SV; Wang, KC; Yu, WY | 1 |
| Non, LR; Pande, A; Romee, R; Santos, CA | 1 |
| Braun, JT; Freter, CE; Lionberger, JM; Petruska, PJ; Ramlal, R; Schoen, MW; Woelich, SK | 1 |
| Berthou, C; Castaigne, S; Cayuela, JM; Cony-Makhoul, P; Deau, B; Gardembas, M; Guerci, A; Guilhot, F; Guilhot, J; Guyotat, D; Hayette, S; Huguet, F; Legros, L; Mahon, FX; Michallet, M; Nicolini, FE; Pautas, C; Réa, D; Rousselot, P; Weiss, IR | 1 |
| Bowler, S; Burr, L; Fanning, S; Wong, D | 1 |
| Chiu, A; Kimball, AB; Kohler, S; McGuire, J | 1 |
| Diehl, V; Glossmann, JP; Josting, A; Staak, JO; Wickenhauser, C | 1 |
| Aydinok, Y; Cetingül, N; Kantar, M; Kavakli, K; Oniz, H | 1 |
| Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L | 1 |
| Bohgaki, T; Kohno, M; Kondo, M; Mukai, M; Notoya, A | 1 |
| Abrahamsson, J; Ek, T; Jarfelt, M; Mellander, L | 1 |
1 review(s) available for cytarabine and Exanthem
| Article | Year |
|---|---|
Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cryptococcus; Cytarabine; Dermatomycoses; Echinocandins; Exanthema; Fever; Fungemia; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipopeptides; Male; Micafungin; Opportunistic Infections; Retrospective Studies; Saccharomyces; Salvage Therapy; Trichosporon; Ustilaginales; Vidarabine; Voriconazole; Yeasts | 2017 |
1 trial(s) available for cytarabine and Exanthem
| Article | Year |
|---|---|
The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Exanthema; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutropenia; Piperazines; Prospective Studies; Pyrimidines; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
14 other study(ies) available for cytarabine and Exanthem
| Article | Year |
|---|---|
Pruritic papules after induction chemotherapy with daunorubicin and cytarabine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Exanthema; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Pruritus; Triamcinolone | 2022 |
Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Diagnosis, Differential; Eosinophilia; Eosinophils; Exanthema; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Molecular Diagnostic Techniques; Skin; Translocation, Genetic; Treatment Outcome; Young Adult | 2017 |
A blueberry muffin rash at birth.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Exanthema; Humans; Infant, Newborn; Leukemia, Monocytic, Acute; Male; Mitoxantrone; Pigmentation Disorders | 2018 |
Congenital acute myeloid leukaemia with KMT2A rearrangement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Exanthema; Female; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein | 2018 |
Florid skin rash in acute myeloid leukaemia.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Drug Eruptions; Exanthema; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged | 2013 |
Generalized benign cutaneous reaction to cytarabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Diagnosis, Differential; Drug Eruptions; Erythema; Exanthema; Female; Humans; Male; Middle Aged; Pruritus; Purpura; Skin Diseases, Vascular; Vasculitis; Young Adult | 2015 |
Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Diarrhea; Exanthema; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Mucositis; Neutropenia; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis.
Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Exanthema; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Radiography | 2012 |
Cytarabine-induced acute generalized exanthematous pustulosis.
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Cytarabine; Drug Eruptions; Exanthema; Female; Humans; Suppuration | 2002 |
Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Arm; Biomarkers, Tumor; Carboxylic Ester Hydrolases; Cerebral Hemorrhage; Cytarabine; Daunorubicin; Exanthema; Fatal Outcome; Humans; Leukosialin; Male; Mitoxantrone; Neoplasm Proteins; Paresis; Sarcoma, Myeloid; Sialoglycoproteins; Skin; Stomach; Testis; Thioguanine; Vimentin | 2003 |
Skin toxicity after administration of low-dose cytarabine.
Topics: Antimetabolites, Antineoplastic; Child; Cytarabine; Erythema Nodosum; Exanthema; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Skin Diseases; Urticaria | 1999 |
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome | 2000 |
Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Exanthema; Humans; Immunophenotyping; Leukemia; Leukemia, Myeloid, Acute; Male | 2001 |
Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Cytokines; Dose-Response Relationship, Drug; Exanthema; Female; Humans; Inflammation; Infusions, Intravenous; Male; Pain; Risk Factors; Tumor Necrosis Factor-alpha | 2001 |